The purpose of this study is to explore the effect of an inflammatory and a psychosocial stressor and the combination thereof on mood in healthy young and elderly participants and patients with Major Depressive Disorder (MDD).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Profile of Mood States (POMS) scores from Baseline to Day 1 of Period 1 and Period 2.
Timeframe: Baseline (pretreatment), Day 1 of Period 1 and Period 2.
Change in Visual Analogue Scale (VAS) scores from Baseline to Day 1 of Period 1 and Period 2.
Timeframe: Baseline (pretreatment), Day 1 of Period 1 and Period 2.
Change in Snaith-Hamilton Pleasure Scale (SHAPS) scores from Baseline to Day 1 of Period 1 and Period 2.
Timeframe: Baseline (pretreatment), Day 1 of Period 1 and Period 2.
Change in Montgomery-Asberg Depression Rating Scale (MADRS) scores from Baseline to Day 1 of Period 1 and Period 2.
Timeframe: Baseline (pretreatment), Day 1 of Period 1 and Period 2.